Provisional Agreement on EU Pharmaceutical Refo...

By João L. Carapinha

December 12, 2025

Provisional Deal Ushers in EU Pharmaceutical Reform The European Parliament and Council have reached a provisional agreement to overhaul the EU's pharmaceutical policy framework, m...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
China Medical Research Challenges: Pushing Boundaries Amid Ethical and Qualit...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Aligning Medical Schemes with National Health Insurance South Africa
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...
UK Risks Underestimating Life Sciences Investment Potential